Menu icon A vertical stack of three evenly spaced horizontal lines. Markets Insider logo The word "Markets Insider". Markets Stocks Indices Commodities Cryptocurrencies Currencies ETFs News Calendar icon An icon in the shape of a calendar. Economic Earnings Search icon A magnifying glass. It indicates, "Click to perform a search". Markets Insider logo The word "Markets Insider". Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. Business Insider logo The words "Business Insider"

TipRanks 178d

Atreca Inc Announces Executive Departures and Consulting Agreements

Benzinga 180d

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

InvestorPlace 199d

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Benzinga 200d

Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

InvestorPlace 200d

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Benzinga 205d

Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

InvestorPlace 205d

Why Is Clearmind Medicine (CMND) Stock Down 24% Today?

Benzinga 205d

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

InvestorPlace 205d

Why Is Tarena International (TCTM) Stock Down 10% Today?

InvestorPlace 205d

Why Is Moolec Science (MLEC) Stock Up 40% Today?

InvestorPlace 205d

Why Is Atreca (BCEL) Stock Up 85% Today?

InvestorPlace 205d

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Benzinga 220d

Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

RTTNews 221d

Immunome To Purchase Antibody Assets From Atreca

GlobeNewswire 221d

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome

Benzinga 221d

Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket

TipRanks 262d

Analysts Offer Insights on Healthcare Companies: Atreca (BCEL), Lucid Diagnostics (LUCD) and Vertex Pharmaceuticals (VRTX)

TipRanks 263d

TD Cowen Remains a Buy on Atreca (BCEL)

GlobeNewswire 263d

Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives

InvestorPlace 271d

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

InvestorPlace 274d

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Benzinga 288d

Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga 288d

Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Benzinga 289d

Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

InvestorPlace 289d

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace 290d

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Benzinga 296d

Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga 297d

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga 297d

Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

GlobeNewswire 317d

Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross

TipRanks 354d

Analysts’ Opinions Are Mixed on These Healthcare Stocks: ALX Oncology Holdings (ALXO), Atreca (BCEL) and Sientra (SIEN)

Benzinga 355d

Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023

Benzinga 358d

Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga 358d

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023

GlobeNewswire 359d

Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring

Seeking Alpha 359d

Atreca GAAP EPS of -$0.49 beats by $0.08

InvestorPlace 387d

3 Penny Stocks to Catapult You Into the Millionaires’ Club

Benzinga 409d

Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Seeking Alpha 409d

Ocean Biomedical, PetVivo top healthcare gainers; uniQure, Voyager among losers

TipRanks 424d

Stifel Nicolaus Reaffirms Their Buy Rating on Atreca (BCEL)

Benzinga 425d

Analyst Expectations for Atreca's Future

TipRanks 425d

Atreca (BCEL) Gets a Buy from H.C. Wainwright

TipRanks 432d

Stifel Nicolaus Sticks to Their Buy Rating for Atreca (BCEL)

TipRanks 437d

Stifel Nicolaus Sticks to Their Buy Rating for Atreca (BCEL)

TipRanks 445d

Stifel Nicolaus Remains a Buy on Atreca (BCEL)

TipRanks 450d

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Atreca (BCEL) and Oscar Health (OSCR)

Seeking Alpha 451d

Atreca GAAP EPS of -$0.54 beats by $0.02

TipRanks 481d

Analysts Conflicted on These Healthcare Names: Medtronic (MDT), Atreca (BCEL) and ProQR (PRQR)

Benzinga 492d

The Latest Analyst Ratings for Atreca

TipRanks 492d

Atreca (BCEL) Gets a Buy from Wedbush Follow us on: See also:

Indices

Commodities

Currencies

Stocks

See more - Explore more categoriesYour Privacy Choices California Consumer Privacy Act (CCPA) Opt-Out Icon Insider Logo

ncG1vNJzZmilkae4psDSZ5muq5mjsrS%2FyKeqopyVp3uku8xopZ6vo2SvpLHLZqqtp5Og